Sanjivan - The Organ Donation Blog

January 5, 2009

Steve Jobs and Pancreatic Cancer

Filed under: dKnowledge Bank, news, pancreas — admin @ 10:01 am
Bookmark and Share

It is in the news today that Steve Jobs of Apple fame has been going through some hormone imbalance and hence he has become thin. Blogs and news outlets all around the world were predicting a really bad news but Apple put out a letter from Steve that quelled those rumors.

I missed writing about Pancreatic Cancer before and I thought this may be an appropriate time. Each year almost 40,000 people in the U.S get affected by Pancreatic Cancer. The real bad part is most of these people die from the disease. The most common form of Pancreatic Cancer is called Adenocarcinoma and it carries a life expectancy of about a year or so. Fortunately Steve Jobs had an another form of Pancreatic Cancer called Neuroendocrine also called as islet cell tumors. These tumors can be surgically removed and does not involve any radiation or chemotheraphy.

And about Steve’s hormone imbalance - he is getting treatment for that and should be getting fatter by next Spring.

November 8, 2008

Cord Blood Donation and leukemia

Filed under: dKnowledge Bank — admin @ 1:38 am
Bookmark and Share

The general terminology “cord blood unit” is used for the blood collected from the umbilical cord and placenta usually after the baby is born. Blood-forming cells are usually present in higher number in Cord blood and it is very effective when used in transplants for patients with leukemia, lymphoma and other life threatening diseases. Cord blood is one of the three sources of cells used in transplant.We looked at the other types - PBSC and bone marrow previously.

September 1, 2008

Types of Bone Marrow Donation

Filed under: bone marrow, dKnowledge Bank — admin @ 10:00 am
Bookmark and Share

There are two popular ways in which stem cells can be donated.

1. Peripheral blood stem cell collection (PBSC)

2. Marrow Harvest

Peripheral Blood Stem Cell collection (PBSC)

Peripheral blood stem cell collection is the latest method to retrieve stem cells from a donor. You are injected with a Filgrastim, a stem cell growth factor medication that increases your stem cell production. Then these stem cells are collected by a procedure called Apheresis, which is similar to dialysis. Blood is retrieved from a vein and sent to a system that collects the excess stem cells and blood is returned to you in the same process. Thus this is a much simpler procedure to donate stem cells.

PBSC is also the most prevalent method of donating stem cells.

Marrow Harvest

This is a surgical procedure that lasts for an hour or so where you are under general anesthesia. A small portion of the liquid bone marrow is removed underneath your hipbone/pelvic bone using sterile syringes. The removed portion is replenished automatically by your body within 4 to 6 weeks.

May 20, 2008

Causes and Risk Factors for Acute Myeloid Leukemia (AML)

Filed under: bone marrow, dKnowledge Bank — admin @ 8:16 am
Bookmark and Share

Although, the following factors can increase the chance of getting the disease, we could never say for certain that these situations will definitly cause the disease.

Smoking

This is the only proven lifestyle related risk factor. It is a well known fact that smoking is related to cancers of lungs, mouth, throat and larynx (voice box). People, often, do not think that smoking can affect cells that do not come in direct contact with smoke. Particles that cause cancer in the tobacco smoke are absorbed by lungs. They are then spread to different parts of the body through the blood stream. Almost one out of five cases of AML is directly related to smoking.

Chemical Exposure

Long exposure to chemicals such as benzene can be another risk factor. Typically industries related to drugs, rubber and synthetic materials use benzene a lot and people who work in those environments can get AML.

Patients with other cancers who are treated with certain chemotherapy drugs are more likely to develop AML. Some of the drugs linked with these secondary (treatment-related) leukemias include mechlorethamine, procarbazine, chlorambucil, etoposide, teniposide and cyclophosphamide. Combining these drugs with radiation therapy further increases the risk.

Most secondary cases of AML occur within 10 years after treatment of Hodgkin disease, non-Hodgkin lymphoma, or childhood acute lymphocytic leukemia (ALL). Secondary leukemias also sometimes occur following treatment of breast, ovarian, or other cancers.

Radiation Exposure

High-dose radiation exposure (such as being a survivor of an atomic bomb blast or nuclear reactor accident) increases the risk of developing AML. Japanese atomic bomb survivors had a greatly increased risk of developing acute leukemia, usually within 6 to 8 years after exposure.

The possible risks of leukemia from exposure to lower levels of radiation, such as from radiation therapy, x-rays, or CT scans, is not well-defined. Exposure of a fetus to radiation within the first months of development may also carry an increased risk of leukemia, although the extent of the risk is not clear. If there is an increased risk it is likely to be small, but to be safe, most doctors try to limit a person’s exposure to radiation as much as possible.

Certain blood disorders

Patients with certain blood disorders seem to be at increased risk for getting AML. These include chronic myeloproliferative disorders such as polycythemia vera, essential thrombocytopenia, and idiopathic myelofibrosis. Chronic myelogenous leukemia (CML) is another type of myeloproliferative disorder, and some patients with CML can later develop a form of AML. The risk of developing AML is increased further if treatment for these disorders includes some types of chemotherapy or radiation.

Some patients who have a myelodysplastic syndrome (preleukemic condition) may develop AML. These conditions cause defects in blood cell formation, and over a period of years may evolve into leukemia. Patients who develop AML after a preleukemic condition typically have a poor prognosis.

Inherited Syndromes

Acute myeloid leukemia does not appear to be an inherited disease. It does not seem to run in families, so a person’s risk is not usually increased if a family member has the disease. But there are some inherited syndromes with genetic changes that seem to raise the risk of AML. These include:

  • Down syndrome
  • Fanconi anemia
  • Bloom syndrome
  • Ataxia-telangiectasia
  • Blackfan-Diamond syndrome

Having an identical twin with AML

This risk is largely confined to the first year of life. As mentioned above, most cases of AML are not thought to have a strong genetic link. Many doctors feel the increased risk among identical twins may be due to leukemia cells being passed from one fetus to the other while still in the womb.

Gender

AML is more common in males than in females, although the reasons for this are not clear.

Uncertain, unproven or controversial risk factors: Other factors that have been studied for a possible link to AML include:

  • exposure to electromagnetic fields (such as living near power lines)
  • workplace exposure to diesel, gasoline, and certain other chemicals and solvents
  • exposure to herbicides

So far, none of these factors has been linked conclusively to AML. Research in these areas is ongoing.

April 25, 2008

Symptoms of Acute Myeloid Leukemia

Filed under: bone marrow, dKnowledge Bank — srini @ 9:42 am
Bookmark and Share

Symptoms
* Abnormal menstrual periods
* Bleeding from the nose
* Bleeding gums
* Bruising
* Bone pain or tenderness
* Fatigue
* Fever
* Paleness
* Shortness of breath (gets worse with exercise)
* Skin rash or lesion
* Swollen gums (rare)
* Weight loss

Newer Posts »

Powered by WordPress